Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04611867 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

Study acronym: BetterEveryDay
StatusRecruiting
PhaseNot applicable
Started2021-08-17
View on ClinicalTrials.gov ↗
Pancreatic and biliary tract cancer are ones of the leading causes of cancer-related deaths. During the course of illness, these patients often experience marked physical suffering, psychological distress and frequent unplanned resource-demanding hospitalized care. Patients with pancreatic and lung cancer have highest rates of unplanned hospitalizations. Investigator initiated prospective "Study of Supportive Application with Integrated Patient-Reported Outcomes in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)" is to be initiated based on the great need for optimizing treatment care, reducing hospitalizations and improving outcomes.

Amendment history 2 changes detected by DataLookout

2026-09-03
Primary completion pushed: 2026-04-01 → 2027-08-01
2026-09-03
Completion pushed: 2027-04-01 → 2027-08-01
Trial Details
NCT Number NCT04611867
Lead Sponsor Inna Chen, MD
Collaborators: Roche Pharma AG
Conditions Pancreatic Cancer, Lung Cancer, Nonsmall Cell
Enrollment 274 participants
Start Date 2021-08-17
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-02